Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Mar;55(3):633-652.
doi: 10.1002/jmri.27849. Epub 2021 Aug 5.

Integrated Cardiopulmonary MRI Assessment of Pulmonary Hypertension

Affiliations
Free article
Review

Integrated Cardiopulmonary MRI Assessment of Pulmonary Hypertension

Laura C Saunders et al. J Magn Reson Imaging. 2022 Mar.
Free article

Abstract

Pulmonary hypertension (PH) is a heterogeneous condition that can affect the lung parenchyma, pulmonary vasculature, and cardiac chambers. Accurate diagnosis often requires multiple complex assessments of the cardiac and pulmonary systems. MRI is able to comprehensively assess cardiac structure and function, as well as lung parenchymal, pulmonary vascular, and functional lung changes. Therefore, MRI has the potential to provide an integrated functional and structural assessment of the cardiopulmonary system in a single exam. Cardiac MRI is used in the assessment of PH in most large PH centers, whereas lung MRI is an emerging technique in patients with PH. This article reviews the current literature on cardiopulmonary MRI in PH, including cine MRI, black-blood imaging, late gadolinium enhancement, T1 mapping, myocardial strain analysis, contrast-enhanced perfusion imaging and contrast-enhanced MR angiography, and hyperpolarized gas functional lung imaging. This article also highlights recent developments in this field and areas of interest for future research including cardiac MRI-based diagnostic models, machine learning in cardiac MRI, oxygen-enhanced 1 H imaging, contrast-free 1 H perfusion and ventilation imaging, contrast-free angiography and UTE imaging. EVIDENCE LEVEL: 5 TECHNICAL EFFICACY: Stage 3.

Keywords: cardiac; cardiopulmonary; lung; pulmonary; pulmonary hypertension.

PubMed Disclaimer

References

    1. Galie N, Humbert M, Vachiery JL, et al. ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS) Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Heart J 2015, 2016;37(1):67.
    1. Galie N, McLaughlin VV, Rubin LJ, Simonneau G. An overview of the 6th world symposium on pulmonary hypertension. Eur Respir J 2019;53(1):1802148.
    1. Kiely DG, Elliot CA, Sabroe I, Condliffe R. Pulmonary hypertension: Diagnosis and management. Bmj-Brit Med J 2013;346:f2028.
    1. Hurdman J, Condliffe R, Elliot CA, et al. ASPIRE registry: Assessing the spectrum of pulmonary hypertension identified at a REferral Centre. Eur Respir J 2012;39(4):945-955.
    1. Remy-Jardin M, Ryerson CJ, Schiebler ML, et al. Imaging of pulmonary hypertension in adults: A position paper from the Fleischner society. Eur Respir J 2021;57(1):2004455.

Publication types